BUY HOLD SELL – Imugene (ASX: IMU)

Imugene (IMU) is expected to move into the ASX 200 in the December quarter rebalance. If that happens, fund managers that are benchmarked to the ASX 200 index must consider buying it, and passive funds have to buy it. It also puts the company on the radar of more investors and research houses. For some…